Adult volunteers diagnosed with DM2 and taking Metformin are needed for a clinical study.
Researchers are evaluating the safety and efficacy of Metformin DR in T2DM patients with varying degrees of kidney function.
For more information, call Metabolic Research Institute Inc. (561) 802-3060, ext. 8036 or visit: https://www.metabolic-institute.com/metformin/